Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Cash from Financing Activities (2016 - 2017)

Historic Cash from Financing Activities for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q2 2017 value amounting to $6.7 million.

  • Eledon Pharmaceuticals' Cash from Financing Activities changed N/A to $6.7 million in Q2 2017 from the same period last year, while for Sep 2017 it was $7.1 million, marking a year-over-year increase of 13905.31%. This contributed to the annual value of $133.5 million for FY2024, which is 30440.38% up from last year.
  • Per Eledon Pharmaceuticals' latest filing, its Cash from Financing Activities stood at $6.7 million for Q2 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Cash from Financing Activities peaked at $88.9 million during Q3 2014, and registered a low of -$437000.0 during Q2 2014.
  • Its 5-year average for Cash from Financing Activities is $9.3 million, with a median of $222000.0 in 2015.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 9978.86% in 2015, then skyrocketed by 143882.98% in 2016.
  • Over the past 5 years, Eledon Pharmaceuticals' Cash from Financing Activities (Quarter) stood at $15.5 million in 2013, then plummeted by 59.57% to $6.3 million in 2014, then tumbled by 99.23% to $48000.0 in 2015, then surged by 5927.08% to $2.9 million in 2016, then surged by 132.25% to $6.7 million in 2017.
  • Its last three reported values are $6.7 million in Q2 2017, $400000.0 for Q1 2017, and $2.9 million during Q3 2016.